Croda Q3 driven by strong personal care results

By Simon Pitman

- Last updated on GMT

Croda Q3 driven by strong personal care results

Related tags Personal care United states dollar

Croda has revealed continued strong growth for its third quarter, a result that it says has been driven by a particularly strong personal care business and one that keeps it on track for its full year targets.

The company said that in reported terms, its sales during the quarter grew by 6.3% to £334.6million, compared to a Q3 2016 of £315.3m.

However, this figure was negatively impacted by currency translations to the effect of 1.7%, mainly due to a strong US dollar. This meant that constant currency sales were up by 4.4%.

Strong personal care results

The personal care division led the way, recording a constant currency sales increase of 7.5%, a figure that built on improved figures for the division recorded in the first six months of the financial year.

The other two major divisions in the business are Performance Technologies, which recorded a robust constant sales increase of 7.0%, while the Life Sciences division recorded much slower constant sales growth, at just 0.7%.

Year-to-date sales were up 12.8%, which included a currency translation benefit of 8.8%, while Q3 profit margin increased slightly compared to the previous year.

Expansion into fast growing geographies

Most of the company’s organic growth has come off the back of an increased exposure to fast growth markets, particularly in North America, where the strong economic growth benefitted the company across all sectors, resulting in sales growth of 8%.

In Asia sales grew by 6%, mainly thanks to a more local approach as the company expands its direct sales model in the region.

Sales in Europe grew by 7%, mainly due to a robust personal care market, while overall sales were 7% lower in Latin America, where macro-economic conditions have continued to impact the company’s operations.

Personal care growth in all regions

Croda reported that its personal care division experienced a good performance across its three main business areas – Beauty Actives, Beauty Formulations and Beauty Effects.

In particular, the company said that the Beauty Actives business continues its strong sales growth, thanks to innovation in fast growth niches in hair, solar and skin treatments by the recently established Beauty Effects team.

The company also added that it is increasing production capacity at Sederma, which is expected to benefit the Beauty Actives business further in the course of 2018.

Related news

Related products

show more

Calendula Cellular Elixir: Alchemy in a cell

Calendula Cellular Elixir: Alchemy in a cell

Content provided by Naolys | 24-Apr-2024 | Product Brochure

Get ready to experience a cellular evolution in skincare with InnerLift Calendula's advanced Plant Cell biotechnology.

See our latest innovations in personal care

See our latest innovations in personal care

Content provided by Covation Bio™ PDO | 02-Apr-2024 | White Paper

At CovationBio PDO, we’re helping the world achieve its sustainability goals by enabling better performing, better-for-the planet products across a range...

Collagen Reimagined, Discover Biodesigned Type XXI

Collagen Reimagined, Discover Biodesigned Type XXI

Content provided by Geltor | 20-Mar-2024 | Product Brochure

Collagen is the body’s most abundant protein and a mainstream ingredient for beauty. Type XXI collagen transcends a common protein into a powerful bioactive

Empowering natural barrier function for future-proof skin

Empowering natural barrier function for future-proof skin

Content provided by Lucas Meyer Cosmetics | 14-Mar-2024 | White Paper

Corneopeptyl™ is a new patented peptide biomimetic to the LCE6A protein, obtained by green chemistry-based synthesis. By mimicking the LCE6A protein activity,...

Related suppliers